๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Intravenous vincristine infusion: Phase I trial

โœ Scribed by Don V. Jackson Jr.; V. Sagar Sethi; Charles L. Spurr; Virgil Willard; Frederick Richards II; John J. Stuart; Hyman B. Muss; M. Robert Cooper; Howard D. Homesley; Vernon W. Jobson; Manford C. Castle

Publisher
John Wiley and Sons
Year
1981
Tongue
English
Weight
555 KB
Volume
48
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

A phase I trial of dactinomycin intraven
A phase I trial of dactinomycin intravenous infusion in patients with advanced malignancies
โœ Martin S. Blumenreich; Thomas M. Woodcock; Stephen P. Richman; Mariesa K. Jones; ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 204 KB ๐Ÿ‘ 3 views

Eighteen patients with advanced malignancies refractory to other forms of treatment were given dactinomycin (Act D) as continuous intravenous infusions. Their median age was 51 years (range, 36-67); their median performance status was 50 (range, 40-90) on the Karnofsky scale. Act D was administered

Long-term intravenous hydroxyurea infusi
Long-term intravenous hydroxyurea infusions in patients with advanced cancer. A phase I trial
โœ Martin S. Blumenreich; Michael J. Kellihan; U. Geetha Joseph; Kim A. Lalley; Eli ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 384 KB ๐Ÿ‘ 1 views

Background. Hydroxyurea is an S-phase specific drug. Constant exposure of tumor cells with a low Sphase fraction to the agent may result in improved cell kill. Because of its short half-life, a continuous intravenous infusion may result in better tumor exposure than intake by mouth. The goal of this

A phase I trial of continuous infusion c
A phase I trial of continuous infusion cisplatin
โœ Marshall R. Posner; Laura Ferrari; James F. Belliveau; Francis J. Cummings; Mich ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 427 KB ๐Ÿ‘ 2 views